Risperidone is a psychiatric drug, mainly used to treat schizophrenia, bipolar disorder, and irritability in people with symptoms of autism. This product is listed in the World Health Organization's standard list of essential medicines and is one of the essential medicines for the basic public health system.

　　Risperidone indications:

　　1. It is used to treat acute and chronic schizophrenia and other various psychotic states with obvious positive symptoms (such as hallucinations, delusions, thinking disorders, hostility, suspicion) and obvious negative symptoms (such as unresponsiveness, apathy, and social Indifferent, less language). It can also alleviate emotional symptoms related to schizophrenia (such as depression, guilt, anxiety). For patients with effective treatment in the acute phase, this product can continue to exert its clinical efficacy in the maintenance phase.

　　2. It can be used to treat the manic episodes of bipolar disorder, which are manifested as elevated mood, exaggeration or irritability, excessive self-evaluation, reduced sleep requirements, accelerated speech speed, running thinking, distracted attention, or low judgment ( Including disordered or aggressive behavior).

　　Risperidone is a powerful D2 antagonist that can improve the positive symptoms of schizophrenia, but it causes less motor function inhibition and tonic fainting than classic antipsychotics. It is recommended as a treatment by the US "Expert Medication Guide" The drug of choice for first-onset or recurrent schizophrenia. Risperidone is a new generation of antipsychotics. It has a high affinity with 5-HT2 receptors and dopamine D2 receptors; it can also bind to α1 receptors and has low affinity with H1 receptors and α2 receptors. It does not interact with choline. Can receptor binding.

　　Research pointed out that for patients with psychiatric depression taking venlafaxine combined with Risperidone, the mental state and overall treatment effect of patients are better than that of venlafaxine alone. Both Risperidone and haloperidol can effectively regulate the levels of monoamine neurotransmitters in children with tic disorders and improve symptoms and signs, but Risperidone has fewer adverse reactions.

　　In addition, for the treatment of patients with senile dementia and mental disorders, Risperidone has a better effect, which can effectively improve the patient's mental state and dementia, and will not cause severe adverse reactions in patients, and has high safety. The sales of terminal antipsychotics in public medical institutions in China increased from 5.270 billion yuan in 2013 to 8.355 billion yuan in 2017, with an average growth rate of more than 10%.

　　Risperidone is a second-generation antipsychotic drug with a wide range of clinical applications. Our company can supply imported raw materials.